Simedhealth LLC
Simedhealth LLC was paid $2.39M by Medicaid between Apr 2018 and Dec 2024, across 74 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 62% of everything it billed.
33Billing provider infoSIMEDHEALTH LLC
GAINESVILLE, FL 32607
GAINESVILLE, FL 32607
33aNPI1639680127assigned 10/24/2017
33bProvider typePodiatrist
28Total paid$2.39M
24GClaims155,501
24DCodes billed74
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers
Next to other Podiatrist providers in Florida
Rank by total paid#1 of 211
Median peer was paid$6K
This provider vs. median415×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,420 | $8K | |
| 2019 | 21,239 | $334K | |
| 2020 | 21,745 | $384K | |
| 2021 | 22,382 | $513K | |
| 2022 | 31,425 | $292K | |
| 2023 | 29,337 | $421K | |
| 2024incomplete | 23,953 | $439K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 62% | 79,245 | 63,677 | $1.48M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.2% | 16,141 | 13,250 | $195K |
| 80324 | 6.9% | 1,454 | 1,206 | $166K | |
| 80346 | 2.8% | 2,252 | 1,848 | $66K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.8% | 1,956 | 1,516 | $66K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.4% | 2,070 | 880 | $57K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 1,617 | 1,438 | $44K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.8% | 194 | 178 | $44K |
| 95117 | 1.5% | 5,247 | 2,397 | $37K | |
| 80348 | 1.4% | 3,442 | 2,861 | $34K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.1% | 1,669 | 475 | $25K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 211 | 164 | $23K |
62 more codes
| 99223 | Prolong inpt eval add15 m | <1% | 446 | $21K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 272 | $17K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 287 | $15K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 4,890 | $12K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 237 | $11K |
| 80365 | <1% | 3,053 | $9K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,586 | $7K |
| 80349 | <1% | 2,038 | $5K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,854 | $5K |
| 80354 | <1% | 3,398 | $5K | |
| 80353 | <1% | 3,104 | $5K | |
| 80361 | <1% | 3,115 | $5K | |
| 80061 | Lipid panel | <1% | 1,000 | $4K |
| 0011A | <1% | 228 | $3K | |
| 80373 | <1% | 805 | $3K | |
| 80372 | <1% | 744 | $3K | |
| 80369 | <1% | 886 | $3K | |
| 80358 | <1% | 1,287 | $3K | |
| 94010 | <1% | 228 | $2K | |
| 80359 | <1% | 584 | $2K | |
| 80345 | <1% | 611 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 69 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 673 | $1K |
| 94060 | <1% | 114 | $1K | |
| 83992 | <1% | 459 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 611 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 332 | $932.94 |
| 20610 | <1% | 136 | $890.07 | |
| 80050 | General health panel | <1% | 67 | $889.58 |
| 99443 | <1% | 14 | $749.25 | |
| 0012A | <1% | 198 | $719.74 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 160 | $715.70 |
| 0064A | <1% | 81 | $584.00 | |
| 71250 | <1% | 30 | $564.74 | |
| 99243 | <1% | 15 | $503.91 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 21 | $500.04 |
| 94729 | <1% | 81 | $391.08 | |
| 81003 | <1% | 600 | $302.53 | |
| 0134A | <1% | 23 | $294.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 172 | $286.10 |
| 99307 | <1% | 96 | $181.56 | |
| 88342 | <1% | 37 | $145.78 | |
| 83001 | <1% | 26 | $114.84 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 71 | $110.30 |
| 90686 | <1% | 81 | $99.76 | |
| 80305 | <1% | 16 | $98.32 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 91 | $69.11 |
| 99406 | <1% | 657 | $42.55 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 24 | $40.00 |
| 82043 | <1% | 31 | $18.48 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 251 | $18.23 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 64 | $1.23 |
| 90791 | Psychiatric diagnostic evaluation | 0% | 161 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 539 | $0.00 |
| 88313 | 0% | 36 | $0.00 | |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 67 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 13 | $0.00 |
| 90662 | 0% | 62 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 108 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 23 | $0.00 |
| 82607 | 0% | 18 | $0.00 | |
| 0094A | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUNCANSON, DANIEL (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Southeastern Integrated Medical PL | Gainesville, FL | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.